Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s traded shares stood at 0.41 million during the latest session, with the company’s beta value hitting 2.12. At the last check today, the stock’s price was $0.31, to imply an increase of 5.90% or $0.02 in intraday trading. The PTPI share’s 52-week high remains $2.27, putting it -632.26% down since that peak but still an impressive 29.03% since price per share fell to its 52-week low of $0.22. The company has a valuation of $3.06M, with an average of 8.68 million shares in intraday trading volume over the past 10 days and average of 1.55 million shares over the past 3 months.

Petros Pharmaceuticals Inc (NASDAQ:PTPI) trade information

After registering a 5.90% upside in the latest session, Petros Pharmaceuticals Inc (PTPI) has traded red over the past five days. The 5-day price performance for the stock is -13.10%, and 5.21% over 30 days. With these gigs, the year-to-date price performance is -78.36%. Short interest in Petros Pharmaceuticals Inc (NASDAQ:PTPI) saw shorts transact 0.2 million shares and set a 0.72 days time to cover.

PTPI Dividends

Petros Pharmaceuticals Inc has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s Major holders

Petros Pharmaceuticals Inc insiders hold 8.10% of total outstanding shares, with institutional holders owning 2.29% of the shares at 2.49% float percentage. In total, 2.29% institutions holds shares in the company.